1. Home
  2. MSD vs XGN Comparison

MSD vs XGN Comparison

Compare MSD & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley Emerging Markets Debt Fund Inc.

MSD

Morgan Stanley Emerging Markets Debt Fund Inc.

HOLD

Current Price

$7.47

Market Cap

150.0M

Sector

Finance

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$4.95

Market Cap

138.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSD
XGN
Founded
1993
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.0M
138.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MSD
XGN
Price
$7.47
$4.95
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$13.67
AVG Volume (30 Days)
70.2K
405.8K
Earning Date
01-01-0001
11-04-2025
Dividend Yield
11.26%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$63,599,000.00
Revenue This Year
N/A
$21.76
Revenue Next Year
N/A
$15.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.08
52 Week Low
$6.11
$2.67
52 Week High
$7.46
$12.23

Technical Indicators

Market Signals
Indicator
MSD
XGN
Relative Strength Index (RSI) 57.24 22.66
Support Level $7.37 $5.74
Resistance Level $7.48 $6.75
Average True Range (ATR) 0.06 0.43
MACD 0.01 -0.01
Stochastic Oscillator 90.63 10.30

Price Performance

Historical Comparison
MSD
XGN

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: